Reply to Jakovac: COVID-19, vitamin D, and type I interferon
- PMID: 32672049
- PMCID: PMC7365833
- DOI: 10.1152/ajpendo.00315.2020
Reply to Jakovac: COVID-19, vitamin D, and type I interferon
Keywords: COVID-19; type I IFN; vitamin D.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Comment on
-
COVID-19 and vitamin D-Is there a link and an opportunity for intervention?Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E589. doi: 10.1152/ajpendo.00138.2020. Am J Physiol Endocrinol Metab. 2020. PMID: 32297519 Free PMC article. No abstract available.
References
-
- Munger KL, Köchert K, Simon KC, Kappos L, Polman CH, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Pleimes D, Sandbrink R, Ascherio A, Pohl C. Molecular mechanism underlying the impact of vitamin D on disease activity of MS. Ann Clin Transl Neurol 1: 605–617, 2014. doi: 10.1002/acn3.91. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
